ZTS

Zoetis Inc (ZTS) Stock Price

Closed
ZTS
$78.82
-$1.93(-2.39%)

Content updated: 2026-11-22 22:53:55

Yesterday's Close
$80.75
Today's Open
$80.37
Today's High
$82.89
Today's Low
$78.76
Volume
4.11M shares
52-Week Range
$69.26-$128.13

As of 2026-11-22 22:53:55, Zoetis Inc (ZTS) was quoted at $78.82, a change of -$1.93 (-2.39%) from the previous close. The day's range was $78.76–$82.89, and the 52-week range was $69.26–$128.13.

Why Is Zoetis Inc (ZTS) Stock Falling?

AI Stock Price Analysis

Content updated: 2026-11-20 21:33:38

ZTS fell 2.09% from the prior close to $79.11 after an early push to $83.08 faded, leaving shares below volume-weighted average price (VWAP). The backdrop includes a narrower full-year EPS guidance range issued on November 5 and a new USDA poultry vaccine license on November 19.

Past 1W-6.11%Period Low $78.80Period High $86.58
Past 1M-0.74%Period Low $77.04Period High $89.29
Past 3M+1.95%Period Low $68.77Period High $89.29
Past 1Y-32.02%Period Low $68.77Period High $132.49

About Zoetis Inc (ZTS)

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Ticker / Exchanges
ZTS / NYSE
Industry / Sector
Drug Manufacturers - Specialty & Generic / Healthcare
CEO
Kristin C. Peck
Headquarters
Parsippany,NJ,US
Official Website
https://www.zoetis.com
Listing Date
2013-02-01

Recent Company Events

  • 2027-02-11
    Earnings Report · ExpectedOn 2027-02-11, the 2026/Q4 earnings report is expected to be released.

Zoetis Inc (ZTS) Derivatives Trading

Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

Zoetis Inc (ZTS) Company Financials

Valuation and Shares

Market Cap
$32.14B
P/E Ratio (TTM)
13.34
P/B Ratio
9.73
Shares Outstanding
406.31M shares
Float Shares
405.47M shares
Dividend Yield (TTM)
2.64%

Latest Reported Financials

2026 Q3 Financials

Report Release Date: 2026-11-05

Operating Revenue (Actual)

$2.39B

Same Period Last Year: -0.37%

Earnings per Share (Actual)

$1.75

Same Period Last Year: +2.94%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$8.08B$8.54B$9.25B$9.46B
Net Profit$2.11B$2.34B$2.48B$2.67B
Operating Cash Flow$1.91B$2.35B$2.95B$2.90B

ZTS FAQ

What is the current stock price of Zoetis Inc (ZTS)?

x
As of 2026-11-22 22:53 (UTC+8), the latest available quote for Zoetis Inc (ZTS) is $78.82 USD, with a change of -$1.93 USD (-2.39%) from the previous trading day's close. Current market status: Closed.

Which exchange is ZTS listed on?

x

How has Zoetis Inc stock performed over the past month?

x

What is the market cap of Zoetis Inc?

x

What are Zoetis Inc's latest financial results?

x

What factors may affect the stock price of Zoetis Inc (ZTS)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.